These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 32184028)

  • 1. Diagnostic accuracy of cardiac magnetic resonance imaging for cardiac sarcoidosis in complete heart block patients implanted with magnetic resonance-conditional pacemaker.
    Orii M; Tanimoto T; Ota S; Takagi H; Tanaka R; Fujiwara J; Akasaka T; Yoshioka K
    J Cardiol; 2020 Aug; 76(2):191-197. PubMed ID: 32184028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of cardiac MRI and 18F-FDG positron emission tomography manifestations and regional response to corticosteroid therapy in newly diagnosed cardiac sarcoidosis with complet heart block.
    Orii M; Hirata K; Tanimoto T; Ota S; Shiono Y; Yamano T; Matsuo Y; Ino Y; Yamaguchi T; Kubo T; Tanaka A; Akasaka T
    Heart Rhythm; 2015 Dec; 12(12):2477-85. PubMed ID: 26111805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis.
    Flamée L; Symons R; Degtiarova G; Dresselaers T; Gheysens O; Wuyts W; Van Cleemput J; Bogaert J
    Eur Radiol; 2020 Jul; 30(7):3702-3710. PubMed ID: 32166494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of a magnetic resonance-conditional pacemaker in a patient with cardiac sarcoidosis.
    Ishibashi K; Takeda M; Yamahara Y
    Intern Med; 2013; 52(12):1341-5. PubMed ID: 23774544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac Magnetic Resonance Imaging-Based Screening for Cardiac Sarcoidosis in Patients With Atrioventricular Block Requiring Temporary Pacing.
    Vuorinen AM; Lehtonen J; Pakarinen S; Holmström M; Kivistö S; Kaasalainen T
    J Am Heart Assoc; 2022 Jun; 11(11):e024257. PubMed ID: 35658507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis.
    Wicks EC; Menezes LJ; Barnes A; Mohiddin SA; Sekhri N; Porter JC; Booth HL; Garrett E; Patel RS; Pavlou M; Groves AM; Elliott PM
    Eur Heart J Cardiovasc Imaging; 2018 Jul; 19(7):757-767. PubMed ID: 29319785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study.
    Kebed KY; Carter SV; Flatley E; Ward RP; Moss JD; Appelbaum DE; Singh A; Lang RM; Tung R; Patel AR
    Int J Cardiovasc Imaging; 2021 Apr; 37(4):1361-1369. PubMed ID: 33225427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The usefulness of speckle tracking echocardiography for the prediction of cardiac involvement in patients with biopsy-proven sarcoidosis.
    Jankowska H; Dorniak K; Dudziak M; Glińska A; Sienkiewicz K; Kulawiak-Gałąska D; Fijałkowska J; Dubaniewicz A; Hellmann M
    Echocardiography; 2024 Mar; 41(3):e15777. PubMed ID: 38526991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of cardiac sarcoidosis despite negative findings on serial late gadolinium enhancement with cardiac magnetic resonance imaging/
    Tanaka TD; Nagai T; Nagoshi T; Yoshimura M
    J Nucl Cardiol; 2020 Dec; 27(6):2149-2153. PubMed ID: 31773564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular magnetic resonance in cardiac sarcoidosis with MR conditional pacemaker in situ.
    Quarta G; Holdright DR; Plant GT; Harkness A; Hausenloy D; Hyare H; Moon JC
    J Cardiovasc Magn Reson; 2011 May; 13(1):26. PubMed ID: 21539747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional abnormalities on cardiac magnetic resonance imaging and arrhythmic events in patients with cardiac sarcoidosis.
    Okada DR; Xie E; Assis F; Smith J; Derakhshan A; Gowani Z; Ambale-Venkatesh B; Gilotra NA; Zimmerman SL; Berger RD; Calkins H; Lima JAC; Tandri H; Chrispin J
    J Cardiovasc Electrophysiol; 2019 Oct; 30(10):1967-1976. PubMed ID: 31328324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Cardiac Sarcoidosis.
    Stanton KM; Ganigara M; Corte P; Celermajer DS; McGuire MA; Torzillo PJ; Corte TJ; Puranik R
    Heart Lung Circ; 2017 Nov; 26(11):1191-1199. PubMed ID: 28501519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic utility of fusion
    Okune M; Yasuda M; Soejima N; Kagioka Y; Kakehi K; Kawamura T; Hanaoka K; Kaida H; Ishii K; Nakazawa G; Miyazaki S; Iwanaga Y
    J Nucl Cardiol; 2022 Apr; 29(2):753-764. PubMed ID: 33000410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of cardiac sarcoidosis in patients presenting with cardiac arrest or life-threatening arrhythmias.
    Hatipoglu S; Gardezi SKM; Azzu A; Baksi J; Alpendurada F; Izgi C; Khattar R; Kouranos V; Wells AU; Sharma R; Wechalekar K; Pennell DJ; Mohiaddin R
    Heart; 2023 Apr; 109(10):748-755. PubMed ID: 36627181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis.
    Smedema JP; Snoep G; van Kroonenburgh MP; van Geuns RJ; Dassen WR; Gorgels AP; Crijns HJ
    J Am Coll Cardiol; 2005 May; 45(10):1683-90. PubMed ID: 15893188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
    Ohira H; Birnie DH; Pena E; Bernick J; Mc Ardle B; Leung E; Wells GA; Yoshinaga K; Tsujino I; Sato T; Manabe O; Oyama-Manabe N; Nishimura M; Tamaki N; Dick A; Dennie C; Klein R; Renaud J; deKemp RA; Ruddy TD; Chow BJW; Davies R; Hessian R; Liu P; Beanlands RSB; Nery PB
    Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):259-269. PubMed ID: 26359191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of late gadolinium enhancement MRI and quantitative T2 measurement in cardiac sarcoidosis.
    Yang Y; Safka K; Graham JJ; Roifman I; Zia MI; Wright GA; Balter M; Dick AJ; Connelly KA
    J Magn Reson Imaging; 2014 Mar; 39(3):609-16. PubMed ID: 23720077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QRS-based assessment of myocardial damage and adverse events associated with cardiac sarcoidosis.
    Sobue Y; Harada M; Koshikawa M; Ichikawa T; Yamamoto M; Okuda K; Kato Y; Sarai M; Watanabe E; Ozaki Y
    Heart Rhythm; 2015 Dec; 12(12):2499-507. PubMed ID: 26362576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed contrast-enhanced computed tomography in patients with known or suspected cardiac sarcoidosis: A feasibility study.
    Aikawa T; Oyama-Manabe N; Naya M; Ohira H; Sugimoto A; Tsujino I; Obara M; Manabe O; Kudo K; Tsutsui H; Tamaki N
    Eur Radiol; 2017 Oct; 27(10):4054-4063. PubMed ID: 28382537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementary Role of CMR to Conventional Screening in the Diagnosis and Prognosis of Cardiac Sarcoidosis.
    Kouranos V; Tzelepis GE; Rapti A; Mavrogeni S; Aggeli K; Douskou M; Prasad S; Koulouris N; Sfikakis P; Wells A; Gialafos E
    JACC Cardiovasc Imaging; 2017 Dec; 10(12):1437-1447. PubMed ID: 28330653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.